文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症危重患者一过性与持续性急性肾损伤相关的死亡率和宿主反应异常:一项前瞻性队列研究

Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study.
PubMed 文献 · Intensive Care Med · 2020-06-08
一句话结论脓毒症患者中持续性急性肾损伤(AKI)而非一过性AKI与30天及1年死亡率独立相关,并伴随持续炎症、促凝反应和血管完整性丧失。

该前瞻性队列研究纳入荷兰2个ICU的1545例脓毒症患者,按入ICU48小时内是否满足RIFLE的尿量或肌酐标准及AKI持续时间(持续>48小时定义为持续性)分层。AKI发生率为37.7%,其中18.4%为一过性,81.6%为持续性。持续性AKI与30天及1年死亡率增加独立相关,并与前4天增强且持续的炎症和促凝反应及更严重的血管完整性丧失相关;一过性AKI无此关联。基线血基因表达与AKI存在或演变差异极小。

要点

  • 脓毒症患者AKI发生率为37.7%,其中持续性AKI占81.6%,一过性AKI占18.4%。
  • 持续性AKI(>48小时)而非一过性AKI与30天及1年死亡率增加独立相关。
  • 持续性AKI患者入ICU时疾病严重度评分更高,且更常为严重RIFLE分期(损伤或衰竭)。
  • 持续性AKI较一过性AKI在前4天呈现增强且持续的炎症和促凝反应及更严重的血管完整性丧失。
  • 基线血基因表达对AKI存在或演变的区分差异极小。

适用人群与场景

  • 荷兰2个ICU收治的脓毒症患者,共1545例。
  • AKI定义:入ICU后48小时内满足任何尿量或肌酐RIFLE标准。
  • 持续性AKI定义:AKI持续>48小时;一过性AKI为48小时内恢复。

诊断标准与关键阈值

  • AKI诊断采用RIFLE标准的尿量或肌酐标准,在入ICU后48小时内评估。
  • 持续性AKI定义为AKI持续超过48小时。
  • 严重RIFLE分期指损伤(injury)或衰竭(failure)期。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,纳入1545例脓毒症患者,来自荷兰2个ICU。
  • AKI发生率为37.7%,其中一过性占18.4%,持续性占81.6%。
  • 持续性AKI患者入ICU时疾病严重度评分更高,且更常为严重RIFLE分期(损伤或衰竭)相比一过性AKI患者。
  • 持续性AKI而非一过性AKI与30天及1年死亡率增加独立相关(经混杂因素调整的逻辑回归)。
  • 持续性AKI较一过性AKI在前4天与增强且持续的炎症和促凝反应相关,并伴有更严重的血管完整性丧失。
  • 基线血基因表达与AKI存在或演变差异极小(分析n=392)。
  • 血浆生物标志物分析n=866,反映脓毒症发病通路。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为持续性AKI与脓毒症死亡率独立相关,并伴随持续炎症、促凝反应和血管完整性丧失,相比一过性AKI。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Sepsis is the most frequent cause of acute kidney injury (AKI). The "Acute Disease Quality Initiative Workgroup" recently proposed new definitions for AKI, classifying it as transient or persistent. We investigated the incidence, mortality, and host response aberrations associated with transient and persistent AKI in sepsis patients.

METHODS: A total of 1545 patients admitted with sepsis to 2 intensive care units in the Netherlands were stratified according to the presence (defined by any urine or creatinine RIFLE criterion within the first 48 h) and evolution of AKI (with persistent defined as remaining > 48 h). We determined 30-day mortality by logistic regression adjusting for confounding variables and analyzed 16 plasma biomarkers reflecting pathways involved in sepsis pathogenesis (n = 866) and blood leukocyte transcriptomes (n = 392).

RESULTS: AKI occurred in 37.7% of patients, of which 18.4% was transient and 81.6% persistent. On admission, patients with persistent AKI had higher disease severity scores and more frequently had severe (injury or failure) RIFLE AKI stages than transient AKI patients. Persistent AKI, but not transient AKI, was associated with increased mortality by day 30 and up to 1 year. Persistent AKI was associated with enhanced and sustained inflammatory and procoagulant responses during the first 4 days, and a more severe loss of vascular integrity compared with transient AKI. Baseline blood gene expression showed minimal differences with respect to the presence or evolution of AKI.

CONCLUSION: Persistent AKI is independently associated with sepsis mortality, as well as with sustained inflammatory and procoagulant responses, and loss of vascular integrity as compared with transient AKI.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Uhel F, Peters-Sengers H, Falahi F, et al. Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2020. PMID: 32514599. doi:10.1007/s00134-020-06119-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。